Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

View source ↗

Summary

This clinical trial update summarizes biomarker findings in tumor tissue from patients with stage III, stage IV, or recurrent endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer | Status: COMPLETED